References
- National Cancer Center. 1995 Cancer statistics in Korea
- National Cancer Center. 2002 Cancer statistics in Korea
- American Cancer Society. 2000. California Cancer Facts and Figures 2000. American Cancer Society California Division and Public Health Institute, Atlanta
- Coldtiz GA, Rosner BA, Speizer FE. 1996. Nurses's Health Study Research Group. Risk factors for breast cancer according to family history of breast cancer. J Natl Cancer Inst 88: 365-371 https://doi.org/10.1093/jnci/88.6.365
- Wiseman RA. 2004. Breast cancer: critical data analysis concludes that estrogens are not the cause, however lifestyle changes and alter risk rapidly. J Clin Epidemiol 57: 766-772 https://doi.org/10.1016/j.jclinepi.2003.10.017
- Kelsey JL, Gammon MD, John EM. 1993. Reproductive factors and breast cancer. Epidemiol Rev 15: 36-47 https://doi.org/10.1093/oxfordjournals.epirev.a036115
- Yang JH. 2005. The Effects of foot reflexology on nausea, vomiting and fatigue of breast cancer patients undergoing chemotherapy. J Korean Acad Nurs 35: 177-185
- Fujiki H. 2005. Green tea: health benefits as cancer preventive for humans. Chem Rec 5: 119-132 https://doi.org/10.1002/tcr.20039
- Matassarin-Jacobs E. 1989. The nursing licensure process and the NCLEX-RN. Nurse Educ 14: 32-35 https://doi.org/10.1097/00006223-198911000-00008
- Shimizu M, Deguchi A, Joe AK, Mckoy JF, Moriwaki H, Weinstein IB. 2005. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J Exp Ther Oncol 5: 69-78
- Rice-Evance C. 1999. Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. Proc Soc Exp Biol Med 220: 262-266 https://doi.org/10.1046/j.1525-1373.1999.d01-45.x
- Hermaez JF, Dashwood RH. 1998. Antimutagenic activity of tea towards 2-hydroxyamino-3-methylimidazo[4,5-f]quinoline: effect of tea concentration and brew time on electrophile scavenging. Mutat Res 402(1-2): 299-306 https://doi.org/10.1016/S0027-5107(97)00309-6
- Yamakawa S, Asai T, Uchida T, Matsukawa M, Akizawa T, Oku N. 2004. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Lett 210: 47-55 https://doi.org/10.1016/j.canlet.2004.03.008
- Dong ZG, Ma WY, Huang C, Yang CS. 1997. Inhibition of tumor promoter-induced activator protein-1 activation and cell transformation by tea polyphenols (-)epigallocathechin gallate and theaflavins. Cancer Res 57: 4414-4419
- Cao Y, Cao R. 1999. Angiogenesis inhibited by drinking tea. Nature 398: 381 https://doi.org/10.1038/18793
- Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB. 2005. (-)-Epigallocathechin gallate and polyphenon E inhibit growth and activation of epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 11: 2735-2746 https://doi.org/10.1158/1078-0432.CCR-04-2014
- Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK. 2004. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol 24: 703-710
- Takada M, Ku Y, Hazuto K, Ajiki T. 2002. Inhibitory effect of epigallocathechin-3-gallate on growth and invasion in human biliary tract carcinoma cells. World J Surg 26: 683-686 https://doi.org/10.1007/s00268-001-0290-2
- Cross M, Dexter TM. 1991. Growth factors in development, transformation and tumorigenesis. Cell 64: 271-280 https://doi.org/10.1016/0092-8674(91)90638-F
- Masuda M, Suzui M, Lim JT, Weinstein IB. 2003. Epigallocatechin-3-gallate inhibits activation of HER-2/ neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 15: 3486-3491
- Guo S, Lu J, Subramanian A, Sonenshein GE. 2006. Microarray-assisted pathway analysis identifies mitogen- activated protein kinase signaling as a mediator of resistance to the green tea polyphenol epigallocatechin 3-gallate in her-2/neu-overexpressing breast cancer cells. Cancer Res 15: 5322-5329 https://doi.org/10.1158/0008-5472.CAN-05-4287
- Yeh CW, Chen WJ, Chiang CT, Lin-Shiau SY, Lin JK. 2003. Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: a possible mechanism for their hypolipidemic effects. Pharmacogenomics J 3: 267-276 https://doi.org/10.1038/sj.tpj.6500192
- Cantley LC. 2002. The phosphoinositide 3-kinase family. Science 296: 1655-1657 https://doi.org/10.1126/science.296.5573.1655
- Pianetti S, Guo S, Kavanagh KT, Sonenshein GE. 2002. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res 62: 652-655
- Sah JF, Balasubramanian S, Eckert RL, Rorke EA. 2003. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 26: 12755-12762 https://doi.org/10.1074/jbc.M312333200